N-Acetyl-DL-leucine
98%
- Product Code: 105497
Alias:
N-acetyl-DL-leucine
CAS:
99-15-0
| Molecular Weight: | 173.21 g./mol | Molecular Formula: | C₈H₁₅NO₃ |
|---|---|---|---|
| EC Number: | 202-734-9 | MDL Number: | MFCD00026498 |
| Melting Point: | 160°C | Boiling Point: | |
| Density: | Storage Condition: | -20°C |
Product Description:
N-Acetyl-DL-leucine is primarily used in the field of medical research and treatment, particularly for neurological disorders. It has shown promise in improving symptoms associated with ataxia, a condition that affects coordination, balance, and speech. The compound is believed to enhance cerebellar function, which plays a critical role in motor control. Additionally, it is being explored for its potential neuroprotective effects, which could be beneficial in managing neurodegenerative diseases. Its application extends to clinical trials where it is administered to evaluate its efficacy and safety in patients with movement disorders.
Product Specification:
| Test | Specification |
|---|---|
| Melting Point | 158-162 |
| Purity (%) | 97.5-102.5 |
| Appearance | White To Light Yellow Powder |
| Infrared Spectrometry | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 5.000 | 10-20 days | $15.07 |
+
-
|
| 25.000 | 10-20 days | $30.14 |
+
-
|
| 100.000 | 10-20 days | $82.87 |
+
-
|
| 500.000 | 10-20 days | $323.96 |
+
-
|
N-Acetyl-DL-leucine
N-Acetyl-DL-leucine is primarily used in the field of medical research and treatment, particularly for neurological disorders. It has shown promise in improving symptoms associated with ataxia, a condition that affects coordination, balance, and speech. The compound is believed to enhance cerebellar function, which plays a critical role in motor control. Additionally, it is being explored for its potential neuroprotective effects, which could be beneficial in managing neurodegenerative diseases. Its application extends to clinical trials where it is administered to evaluate its efficacy and safety in patients with movement disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :